Literature DB >> 24142516

TACE in perinatal mouse lung epithelial cells promotes lung saccular formation.

Wei Xu1, Chengyu Liu, Vesa Kaartinen, Hui Chen, Chi-Han Lu, Wenming Zhang, Yongfeng Luo, Wei Shi.   

Abstract

Tumor necrosis factor-α converting enzyme (TACE) is a cell membrane sheddase, expressed in both developmental lung epithelia and mesenchyme. Global abrogation of TACE results in neonatal lethality and multiple organ developmental abnormalities, including dysplastic lung. To further define the roles of TACE in regulating lung development, lung epithelial and/or mesenchymal specific TACE conditional knockout mice were generated. Blockade of TACE function in developing lung epithelial cells caused reduced saccular formation, decreased cell proliferation, and reduced mid-distal lung epithelial cell differentiation. In contrast, mesenchymal TACE knockout did not have any phenotypic change in developing lung. Simultaneous abrogation of TACE in both lung epithelial and mesenchymal cells did not result in a more severe lung abnormality. Interestingly, these lung-specific TACE conditional knockout mice were not neonatal lethal, and their lung structures were essentially normal after alveolarization. In addition, TACE conditional knockout in developing cardiomyocytes resulted in noncompaction of ventricular myocardium, as seen in TACE conventional knockout mice. However, these mice were also not neonatal lethal. In conclusion, lung epithelial TACE is essential for promoting fetal lung saccular formation, but not postnatal lung alveolarization in mice. Because the developmental abnormality of either lung or heart induced by TACE deficiency does not directly lead to neonatal lethality, the neonatal death of TACE conventional knockout mice is likely a result of synergistic effects of multiple organ abnormalities.

Entities:  

Keywords:  lung development; tumor necrosis factor-α converting enzyme

Mesh:

Substances:

Year:  2013        PMID: 24142516      PMCID: PMC3882534          DOI: 10.1152/ajplung.00189.2013

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  27 in total

1.  Direct removal in the mouse of a floxed neo gene from a three-loxP conditional knockout allele by two novel approaches.

Authors:  X Xu; C Li; L Garrett-Beal; D Larson; A Wynshaw-Boris; C X Deng
Journal:  Genesis       Date:  2001-05       Impact factor: 2.487

2.  Dermo-1: a novel twist-related bHLH protein expressed in the developing dermis.

Authors:  L Li; P Cserjesi; E N Olson
Journal:  Dev Biol       Date:  1995-11       Impact factor: 3.582

3.  A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells.

Authors:  F Schwenk; U Baron; K Rajewsky
Journal:  Nucleic Acids Res       Date:  1995-12-25       Impact factor: 16.971

4.  Pulmonary hypoplasia in mice lacking tumor necrosis factor-alpha converting enzyme indicates an indispensable role for cell surface protein shedding during embryonic lung branching morphogenesis.

Authors:  J Zhao; H Chen; J J Peschon; W Shi; Y Zhang; S J Frank; D Warburton
Journal:  Dev Biol       Date:  2001-04-01       Impact factor: 3.582

5.  Embryonic expression of an Nkx2-5/Cre gene using ROSA26 reporter mice.

Authors:  K A Moses; F DeMayo; R M Braun; J L Reecy; R J Schwartz
Journal:  Genesis       Date:  2001-12       Impact factor: 2.487

6.  TACE is required for fetal murine cardiac development and modeling.

Authors:  Wei Shi; Hui Chen; Jianping Sun; Sue Buckley; Jingsong Zhao; Kathryn D Anderson; Roberta G Williams; David Warburton
Journal:  Dev Biol       Date:  2003-09-15       Impact factor: 3.582

7.  gamma -Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase.

Authors:  C Y Ni; M P Murphy; T E Golde; G Carpenter
Journal:  Science       Date:  2001-10-25       Impact factor: 47.728

8.  Stretch-induced fetal type II cell differentiation is mediated via ErbB1-ErbB4 interactions.

Authors:  Zheping Huang; Yulian Wang; Pritha S Nayak; Christiane E Dammann; Juan Sanchez-Esteban
Journal:  J Biol Chem       Date:  2012-04-09       Impact factor: 5.157

9.  Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth.

Authors:  Kai Yu; Jingsong Xu; Zhonghao Liu; Drazen Sosic; Jiansu Shao; Eric N Olson; Dwight A Towler; David M Ornitz
Journal:  Development       Date:  2003-07       Impact factor: 6.868

10.  Hemagglutinin from the H5N1 virus activates Janus kinase 3 to dysregulate innate immunity.

Authors:  Wei Xu; Minhui Chen; Nanhai Ge; Jun Xu
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

View more
  5 in total

Review 1.  Novel regulators of endothelial barrier function.

Authors:  Dolly Mehta; Krishnan Ravindran; Wolfgang M Kuebler
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-11-07       Impact factor: 5.464

2.  Structural modeling defines transmembrane residues in ADAM17 that are crucial for Rhbdf2-ADAM17-dependent proteolysis.

Authors:  Xue Li; Thorsten Maretzky; Jose Manuel Perez-Aguilar; Sébastien Monette; Gisela Weskamp; Sylvain Le Gall; Bruce Beutler; Harel Weinstein; Carl P Blobel
Journal:  J Cell Sci       Date:  2017-01-19       Impact factor: 5.285

3.  Neuregulin-ErbB4 signaling in the developing lung alveolus: a brief review.

Authors:  Najla Fiaturi; John J Castellot; Heber C Nielsen
Journal:  J Cell Commun Signal       Date:  2014-05-31       Impact factor: 5.782

Review 4.  Neutrophilic Inflammation in the Immune Responses of Chronic Obstructive Pulmonary Disease: Lessons from Animal Models.

Authors:  Gang Huang; Xu-Chen Xu; Jie-Sen Zhou; Zhou-Yang Li; Hai-Pin Chen; Yong Wang; Wen Li; Hua-Hao Shen; Zhi-Hua Chen
Journal:  J Immunol Res       Date:  2017-04-23       Impact factor: 4.818

Review 5.  The EGFR-ADAM17 Axis in Chronic Obstructive Pulmonary Disease and Cystic Fibrosis Lung Pathology.

Authors:  Marta Stolarczyk; Bob J Scholte
Journal:  Mediators Inflamm       Date:  2018-01-09       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.